fda tirzepatide compound update The says it's standing by its earlier decision that the shortage of — the active ingredient in Eli Lilly's diabetes and weight loss drugs Mounjaro and Zepbound — is over FDA ban on compounded tirzepatide:

Whether through dietary support or targeted pharmaceutical solutions like the ReadyRx Injection Program, prioritizing glutathione is a proactive step toward sustaining health, vitality, and well-being in 2025 and beyond

A wealth of literature indicates that a significant portion of the hypophagic effects of current GLP-1R agonists are mediated by GLP-1Rs expressed in the CNS, in particular those in the AP/NTS (3742)

Peccatori FA, Azim HA Jr, Orecchia R, ESMO Guidelines Working Group, et al

Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes. Both drugs were also linked to acceptable safety profiles. Krger et al

For any serious or severe side effects, please seek immediate in-person medical care

While cancer vaccines have shown limited success as monotherapies in GI cancers, they are being investigated in combination with other immunotherapies or standard treatments, such as chemotherapy or radiation therapy, to enhance their efficacy